ILMN250509C93000
- 0.01
- -0.16-94.12%
Illumina Newsroom
A Quick Look at Today's Ratings for Illumina(ILMN.US), With a Forecast Between $85 to $190
Illumina | 10-Q: Quarterly report
10 Health Care Stocks With Whale Alerts In Today's Session
Illumina Is Maintained at Buy by Guggenheim
Illumina Analyst Ratings
Piper Sandler Remains a Buy on Illumina (ILMN)
Express News | Illumina Inc : TD Cowen Raises Target Price to $89 From $86
Stifel Nicolaus Reaffirms Their Buy Rating on Illumina (ILMN)
Express News | Illumina Inc : Stifel Cuts Target Price to $135 From $160
Citi Maintains Illumina(ILMN.US) With Hold Rating, Maintains Target Price $85
Barclays Maintains Illumina(ILMN.US) With Sell Rating, Cuts Target Price to $77
Express News | Illumina Inc : Guggenheim Cuts Target Price to $114 From $122
Illumina Outlines $4.18B to $4.26B Guidance for 2025 Amid China Headwinds and Strategic Cost Reductions
Research Alert: Ilmn: No Major Surpises In Q1 Results, Yet Guidance Points To Weakened Outlook
Illumina Inc. Stock Outperforms Competitors On Strong Trading Day
Illumina Q1 Non-GAAP Earnings, Revenue Decline; Reduces Full Year Guidance
Illumina Lowers Full-Year Outlook As Result of Tariffs on China
Express News | Illumina Shares Are Trading Lower After the Company Reported Q1 Financial Results and Cut Its FY25 Adjusted EPS Guidance Below Estimates
Unusual Options Activity: MSTR, TECK and Others Attract Market Bets, MSTR V/OI Ratio Reaches 136.4
Express News | Illumina Inc Says FY EPS Outlook Reduction From March Guidance, Primarily Due to Net Impact of Tariffs